Literature DB >> 2166830

Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos.

E Flemington1, S H Speck.   

Abstract

The Epstein-Barr virus BZLF1 gene product ZEBRA is a DNA-binding protein that is partially homologous to c-Fos, binds specifically to AP-1 sites, and can induce the lytic cycle in latently infected B lymphocytes. Induction of the viral lytic cycle can also be achieved by treatment with the phorbol ester 12-O-tetrade-canoylphorbol-13-acetate, a reagent which activates gene expression in part through AP-1 (Jun/Fos). In this article the interrelationship between ZEBRA and AP-1 is extended by the demonstration that ZEBRA can induce c-Fos expression through AP-1 and "AP-1-like" sites present in the c-fos promoter. Induction of c-Fos may be necessary for the expression of other viral lytic genes and perhaps cellular genes whose products are required for viral replication.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166830      PMCID: PMC247926          DOI: 10.1128/JVI.64.9.4549-4552.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.

Authors:  B Kallin; J Luka; G Klein
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences.

Authors:  R Treisman
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

3.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

4.  Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Authors:  J Countryman; H Jenson; R Seibl; H Wolf; G Miller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Identification of a transcriptional enhancer element upstream from the proto-oncogene fos.

Authors:  J Deschamps; F Meijlink; I M Verma
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

7.  Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.

Authors:  G Bauer; P Höfler; H Zur Hausen
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

8.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

9.  Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.

Authors:  E Flemington; S H Speck
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers.

Authors:  J Piette; M Yaniv
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

View more
  36 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.

Authors:  A L Lear; M Rowe; M G Kurilla; S Lee; S Henderson; E Kieff; A B Rickinson
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 3.  Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential.

Authors:  J W Sixbey; P Shirley
Journal:  Springer Semin Immunopathol       Date:  1991

4.  Negative regulation of the BZLF1 promoter of Epstein-Barr virus.

Authors:  E A Montalvo; Y Shi; T E Shenk; A J Levine
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia.

Authors:  T Valyi-Nagy; S Deshmane; A Dillner; N W Fraser
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis.

Authors:  E K Flemington; A E Goldfeld; S H Speck
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Pathways of activation of the Epstein-Barr virus productive cycle.

Authors:  A J Sinclair; M Brimmell; F Shanahan; P J Farrell
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression.

Authors:  A J Sinclair; M Brimmell; P J Farrell
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain.

Authors:  E K Flemington; A M Borras; J P Lytle; S H Speck
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.

Authors:  Wangrong Wen; Dai Iwakiri; Koji Yamamoto; Seiji Maruo; Teru Kanda; Kenzo Takada
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.